JPX : 4569.T

KYORIN Holdings, Inc.

$1142 JPY

-$69 (-5.7%)

Volume
266.1K
Average Volume
222.68K
Market Capitalization
$65.6B
P/E Ratio
30.21
Dividend Yield
4.99%
Price Target
Year High
$1725.00
Year Low
$1067.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$5.18
Company Overview

JPX

Yutaka Ogihara

Drug Manufacturers - Specialty & Generic

Healthcare

4569.T

1982

JP

JPY

https://www.kyorin-pharm.co.jp

81 3 3525 4700

N/A

N/A

Liquidity Metrics

0.17

5.18

2.50

0.54

0.00

Sales & Valuation

$126.26B

0.52

0.47

0.00

0.00

Profitability

$60.02

$3.45B

1.73%

2.32%

1.56%

1.15%

P/E Metrics

30.21

-0.38

-0.38

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

3.15

4/9

$104.99B

$188.61B

$48.3B

$2.16B

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Noriaki Tamura Managing Exe. Officer, Chief Commercial Officer, GM of Pharma Sales Division & Director
Kiyoo Uehara Managing Executive Officer, CHRO & General Affairs Manager
Junichi Ishiyama Managing Executive Officer, CSO & Head of Drug Discovery Div.
Kenichi Nakamura Corporate Officer & President of KYORIN Pharmaceutical Group Facilities Co., Ltd.
Michiro Onota Exe. Director, Mng. Corp. Off., CMO, Chairman of KYORIN Pharmaceutical Grp. Facilities Co., Ltd
Yasuji Kurose CFO, CSO, Managing Executive Officer, Director of Corporate Planning & Executive Director
Yutaka Ogihara President, Chief Executive Officer & Chairman
Takaaki Kaji Senior Managing Executive Officer & Chief Business Development Officer
Poll Results

No votes yet today — be the first to share your view!

About KYORIN Holdings, Inc. (JPX:4569.T) Stock

Based in Tokyo, Japan, and founded in 1923, KYORIN Holdings, Inc. is a pharmaceutical enterprise engaged in the discovery, development, production, and worldwide distribution of both innovative prescription drugs and generic equivalents. Its diverse therapeutic catalog features medications such as Flutiform for asthma; Desalex, an antiallergic agent; and treatments like Beova, Uritos, and Imidafenacin KYORIN for overactive bladder. The company also offers Lasvic, a quinolone antibacterial; Pentasa for managing ulcerative colitis and Crohn's disease; Nasonex and Kipres for allergic rhinitis; and Mucodyne, a mucoregulating compound. Further pharmaceutical products include Montelukast KM, prescribed for bronchial asthma and allergic rhinitis. Beyond drugs, KYORIN Holdings markets specialized ... items like the GeneSoC real-time PCR system, disinfectant solutions such as Rubysta and Milton, over-the-counter remedies, diagnostic tools, industrial chemicals, and various reagents and intermediates. The company extends its services to include contract drug manufacturing and actively participates in early-stage research, including identifying and assessing candidate compounds, analyzing competitor technologies, and collecting data from clinical trials.

Frequently Asked Questions

What is the current KYORIN Holdings, Inc. (4569.T) stock price?

KYORIN Holdings, Inc.(JPX:4569.T) stock price is $1142 in the last trading session. During the trading session, 4569.T stock reached the peak price of $1725 while $1067 was the lowest point it dropped to. The percentage change in 4569.T stock occurred in the recent session was --5.7% while the dollar amount for the price change in 4569.T stock was -$69.

4569.T's industry and sector of operation?

The JPX listed 4569.T is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of 4569.T?

Noriaki Tamura | Managing Exe. Officer, Chief Commercial Officer, GM of Pharma Sales Division & Director
Kiyoo Uehara | Managing Executive Officer, CHRO & General Affairs Manager
Junichi Ishiyama | Managing Executive Officer, CSO & Head of Drug Discovery Div.
Kenichi Nakamura | Corporate Officer & President of KYORIN Pharmaceutical Group Facilities Co., Ltd.
Michiro Onota | Exe. Director, Mng. Corp. Off., CMO, Chairman of KYORIN Pharmaceutical Grp. Facilities Co., Ltd

How many employees does 4569.T have?

Number of 4569.T employees currently stands at 1982. 4569.T operates from 1-3-7, Otemachi, Tokyo, TY 100-0004, JP.

Link for 4569.T official website?

Official Website of 4569.T is: https://www.kyorin-pharm.co.jp

How do I contact 4569.T?

4569.T could be contacted at phone #81 3 3525 4700 and can also be accessed through its website. 4569.T operates from 1-3-7, Otemachi, Tokyo, TY 100-0004, JP.

How many shares of 4569.T are traded daily?

The average number of 4569.T shares traded daily for last 3 months was 222.68K.

What is the market cap of 4569.T currently?

The market value of 4569.T currently stands at $65.6B with its latest stock price at $1142